脊髄刺激装置(SCS):医療機器パイプライン分析

◆英語タイトル:Spinal Cord Stimulators (SCS) - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0162
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:152
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Spinal Cord Stimulators (SCS) – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Spinal Cord Stimulators (SCS) – Medical Devices Pipeline Assessment, 2019″ provides an overview of Spinal Cord Stimulators (SCS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators (SCS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Spinal Cord Stimulators (SCS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Cord Stimulators (SCS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Cord Stimulators (SCS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Spinal Cord Stimulators (SCS) Overview 10
3 Products under Development 11
3.1 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 11
3.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Territory 12
3.3 Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path 13
3.4 Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date 14
3.5 Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials 15
4 Spinal Cord Stimulators (SCS) – Pipeline Products under Development by Companies 16
4.1 Spinal Cord Stimulators (SCS) Companies – Pipeline Products by Stage of Development 16
4.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 17
5 Spinal Cord Stimulators (SCS) Companies and Product Overview 19
5.1 Boston Scientific Corp Company Overview 19
5.1.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Cerevast Therapeutics Inc Company Overview 20
5.2.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Direct Spinal Therapeutics, Inc. Company Overview 21
5.3.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Duke University Company Overview 22
5.4.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 GTX Medical BV Company Overview 23
5.5.1 GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Imperial College London Company Overview 29
5.6.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 Lawson Health Research Institute Company Overview 30
5.7.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Meagan Medical Inc. Company Overview 31
5.8.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.9 Medtronic plc Company Overview 34
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Micro-Leads Inc Company Overview 37
5.10.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.11 MicroTransponder Inc Company Overview 39
5.11.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Neuronoff Inc Company Overview 40
5.12.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.13 Nevro Corp Company Overview 41
5.13.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 41
5.14 Nexstim Plc Company Overview 60
5.14.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 60
5.15 Nuvectra Corp Company Overview 61
5.15.1 Nuvectra Corp Pipeline Products & Ongoing Clinical Trials Overview 61
5.16 Saluda Medical Pty Ltd Company Overview 62
5.16.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 62
5.17 Soterix Medical Inc Company Overview 65
5.17.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 65
5.18 SpineX Company Overview 72
5.18.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview 72
5.19 St. Jude Medical LLC Company Overview 73
5.19.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73
5.20 University of California Los Angeles Company Overview 77
5.20.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 77
5.21 University of Minnesota Company Overview 79
5.21.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 79
5.22 Wavegate Technologies LLC Company Overview 82
5.22.1 Wavegate Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82
5.23 WISE s.r.l. Company Overview 83
5.23.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 83
6 Spinal Cord Stimulators (SCS)- Recent Developments 84
6.1 Nov 25, 2019: Stimwave Technologies halts commercialization of product line in Australia 84
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
6.4 Nov 12, 2019: Nuvectra continuing to support current patients with the Algovita Implant as company voluntarily files for chapter 11 88
6.5 Nov 08, 2019: University of Wisconsin Madison: Injectable, flexible electrode could replace rigid nerve-stimulating implants 88
7 Appendix 149
7.1 Methodology 149
7.2 About GlobalData 152
7.3 Contact Us 152
7.4 Disclaimer 152

List of Tables
Table 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Table 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Table 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Table 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials
Table 6: Spinal Cord Stimulators (SCS) Companies - Pipeline Products by Stage of Development
Table 7: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Table 8: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Next Generation SCS System - Product Status
Table 10: Next Generation SCS System - Product Description
Table 11: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Transdermal Electrical Neurostimulation Device - Product Status
Table 13: Transdermal Electrical Neurostimulation Device - Product Description
Table 14: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Iowa-Patch System - Product Status
Table 16: Iowa-Patch System - Product Description
Table 17: Duke University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Spinal Cord Stimulator - Product Status
Table 19: Spinal Cord Stimulator - Product Description
Table 20: GTX Medical BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: External Transcutaneous Spinal Cord Stimulation Device - Product Status
Table 22: External Transcutaneous Spinal Cord Stimulation Device - Product Description
Table 23: Targeted Epidural Spinal Stimulation Device - Product Status
Table 24: Targeted Epidural Spinal Stimulation Device - Product Description
Table 25: GTX Medical BV - Ongoing Clinical Trials Overview
Table 26: External Transcutaneous Spinal Cord Stimulation Device - Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
Table 27: Targeted Epidural Spinal Stimulation Device - Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO)
Table 28: Targeted Epidural Spinal Stimulation Device - Enabling Forelimb Function with Agonist Drug and Epidural Stimulation in SCI
Table 29: Targeted Epidural Spinal Stimulation Device - Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 30: Targeted Epidural Spinal Stimulation Device - Task and Physiological Specific Stimulation for Recovery of Autonomic Function, Voluntary Movement, and Standing Using Epidural Stimulation and Training After Severe Spinal Cord Injury
Table 31: Targeted Epidural Spinal Stimulation Device - Task-specific Epidural Stimulation and Training for Recovery of Stepping, Standing and Voluntary Movement Following Severe Spinal Cord Injury
Table 32: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Wireless Intraspinal Microstimulation System - Product Status
Table 34: Wireless Intraspinal Microstimulation System - Product Description
Table 35: Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Spinal Implant - Parkinson’s Disease - Product Status
Table 37: Spinal Implant - Parkinson’s Disease - Product Description
Table 38: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: DISCSS IFC System - Product Status
Table 40: DISCSS IFC System - Product Description
Table 41: Meagan Medical Inc. - Ongoing Clinical Trials Overview
Table 42: DISCSS IFC System - Pilot Study to Examine the Feasibility of the DISCSS
Table 43: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: MRI Surgical Lead - Product Status
Table 45: MRI Surgical Lead - Product Description
Table 46: Next Generation Intellis - Product Status
Table 47: Next Generation Intellis - Product Description
Table 48: PrimeADVANCED - Heart Failure - Product Status
Table 49: PrimeADVANCED - Heart Failure - Product Description
Table 50: Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: HD64 Implantable Therapy System - Product Status
Table 52: HD64 Implantable Therapy System - Product Description
Table 53: Intelligent Spinal Interface - Product Status
Table 54: Intelligent Spinal Interface - Product Description
Table 55: MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: SAINT System - Chronic Pain - Product Status
Table 57: SAINT System - Chronic Pain - Product Description
Table 58: Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Injectrode - Product Status
Table 60: Injectrode - Product Description

List of Figures
Figure 1: Spinal Cord Stimulators (SCS) - Pipeline Products by Stage of Development
Figure 2: Spinal Cord Stimulators (SCS) - Pipeline Products by Territory
Figure 3: Spinal Cord Stimulators (SCS) - Pipeline Products by Regulatory Path
Figure 4: Spinal Cord Stimulators (SCS) - Pipeline Products by Estimated Approval Date
Figure 5: Spinal Cord Stimulators (SCS) - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[脊髄刺激装置(SCS):医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆